Butyzamide is an effective and oral Mpl activator. It is a novel non-peptide-based molecule with antagonistic effects on thrombopoietin (TPO) receptors, which promotes proliferation of human Mpl (hMpl) expression and mouse pro B cell line Ba/F3. The phosphorylation of JAK2, STAT3, STAT5 and MAPK is induced. Butyzamide has been shown to help increase platelet levels in mouse xenotransplantation trials.
Molekulargewicht:
591.55
Reinheit:
>99.99%
CAS Nummer:
[1110767-45-7]
Formel:
C29H32Cl2N2O5S
Target-Kategorie:
p38 MAPK|||JAK|||STAT|||Thrombopoietin Receptor
T67894
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten